(Q41169571)

27 September 2017

1 reference

title

Statins do more than just lower cholesterol (English)

1 reference

27 September 2017

C J Vaughan

1

1 reference

27 September 2017

M B Murphy

series ordinal

2

1 reference

27 September 2017

B M Buckley

series ordinal

3

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

27 September 2017

1 reference

27 September 2017

348

1 reference

27 September 2017

1079-1082

1 reference

27 September 2017

9034

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

The biology of platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Effects of lovastatin on natural killer cell function and other immunological parameters in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Postischemic blood flow response in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Effects of long-term treatment with lovastatin on the clotting system and blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Platelet cytosolic Ca2+ and membrane dynamics in patients with primary hypercholesterolemia. Effects of pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2905190-2

7 January 2021

10.1016/S0140-6736(96)05190-2

Identifiers

DOI

1 reference

27 September 2017

1 reference